

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | oligosaccharide biosynthetic process (GO:0009312) | 9.65431525 |
| 2 | response to phenylpropanoid (GO:0080184) | 6.32429205 |
| 3 | ceramide catabolic process (GO:0046514) | 4.91536488 |
| 4 | exogenous drug catabolic process (GO:0042738) | 4.77897746 |
| 5 | cellular glucuronidation (GO:0052695) | 4.73435577 |
| 6 | uronic acid metabolic process (GO:0006063) | 4.71515407 |
| 7 | glucuronate metabolic process (GO:0019585) | 4.71515407 |
| 8 | negative regulation of execution phase of apoptosis (GO:1900118) | 4.71437276 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.71295724 |
| 10 | low-density lipoprotein particle clearance (GO:0034383) | 4.69064209 |
| 11 | cholesterol catabolic process (GO:0006707) | 4.68734325 |
| 12 | sterol catabolic process (GO:0016127) | 4.68734325 |
| 13 | alpha-linolenic acid metabolic process (GO:0036109) | 4.64564667 |
| 14 | * lactation (GO:0007595) | 4.55288797 |
| 15 | regulation of triglyceride catabolic process (GO:0010896) | 4.48424443 |
| 16 | complement activation, alternative pathway (GO:0006957) | 4.46973772 |
| 17 | ectoderm development (GO:0007398) | 4.16354078 |
| 18 | mammary gland epithelial cell differentiation (GO:0060644) | 4.09694707 |
| 19 | plasma lipoprotein particle clearance (GO:0034381) | 4.06863141 |
| 20 | drug metabolic process (GO:0017144) | 4.02421714 |
| 21 | phospholipid homeostasis (GO:0055091) | 3.96341775 |
| 22 | urea metabolic process (GO:0019627) | 3.94239324 |
| 23 | urea cycle (GO:0000050) | 3.94239324 |
| 24 | regulation of sequestering of triglyceride (GO:0010889) | 3.93349201 |
| 25 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.93011508 |
| 26 | intestinal cholesterol absorption (GO:0030299) | 3.90649008 |
| 27 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.85880189 |
| 28 | phospholipid efflux (GO:0033700) | 3.85691720 |
| 29 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.80483726 |
| 30 | regulation of protein activation cascade (GO:2000257) | 3.78670554 |
| 31 | omega-hydroxylase P450 pathway (GO:0097267) | 3.78413764 |
| 32 | ethanol metabolic process (GO:0006067) | 3.77617464 |
| 33 | regulation of cholesterol storage (GO:0010885) | 3.77399142 |
| 34 | * secretion by tissue (GO:0032941) | 3.76047371 |
| 35 | regulation of complement activation (GO:0030449) | 3.72238463 |
| 36 | complement activation, classical pathway (GO:0006958) | 3.71913603 |
| 37 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.71379537 |
| 38 | GDP-mannose metabolic process (GO:0019673) | 3.70943542 |
| 39 | fatty acid transmembrane transport (GO:1902001) | 3.67848724 |
| 40 | positive regulation of lipid catabolic process (GO:0050996) | 3.63699312 |
| 41 | arginine metabolic process (GO:0006525) | 3.63345722 |
| 42 | protein carboxylation (GO:0018214) | 3.62793333 |
| 43 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.62793333 |
| 44 | L-phenylalanine catabolic process (GO:0006559) | 3.62431083 |
| 45 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.62431083 |
| 46 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.62257275 |
| 47 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.62257275 |
| 48 | glutathione biosynthetic process (GO:0006750) | 3.59059972 |
| 49 | nitrogen cycle metabolic process (GO:0071941) | 3.56503415 |
| 50 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.48796746 |
| 51 | L-phenylalanine metabolic process (GO:0006558) | 3.48796746 |
| 52 | sphingolipid catabolic process (GO:0030149) | 3.48184881 |
| 53 | cholesterol efflux (GO:0033344) | 3.47664940 |
| 54 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.47464601 |
| 55 | high-density lipoprotein particle remodeling (GO:0034375) | 3.47281348 |
| 56 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.45878444 |
| 57 | oligosaccharide metabolic process (GO:0009311) | 3.45624779 |
| 58 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.44764275 |
| 59 | epoxygenase P450 pathway (GO:0019373) | 3.44238573 |
| 60 | plasma lipoprotein particle assembly (GO:0034377) | 3.43318319 |
| 61 | steroid catabolic process (GO:0006706) | 3.42885434 |
| 62 | reverse cholesterol transport (GO:0043691) | 3.41057311 |
| 63 | regulation of cholesterol esterification (GO:0010872) | 3.39229734 |
| 64 | intestinal absorption (GO:0050892) | 3.39105238 |
| 65 | digestive system process (GO:0022600) | 3.37165680 |
| 66 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.36105047 |
| 67 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.34967263 |
| 68 | * body fluid secretion (GO:0007589) | 3.34640725 |
| 69 | regulation of phospholipid biosynthetic process (GO:0071071) | 3.34234813 |
| 70 | triglyceride biosynthetic process (GO:0019432) | 3.31626309 |
| 71 | triglyceride homeostasis (GO:0070328) | 3.30946828 |
| 72 | acylglycerol homeostasis (GO:0055090) | 3.30946828 |
| 73 | sulfur amino acid catabolic process (GO:0000098) | 3.29188110 |
| 74 | lipoprotein metabolic process (GO:0042157) | 3.28738032 |
| 75 | protein-lipid complex assembly (GO:0065005) | 3.28691222 |
| 76 | negative regulation of complement activation (GO:0045916) | 3.26983559 |
| 77 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.26955949 |
| 78 | negative regulation of protein activation cascade (GO:2000258) | 3.26029746 |
| 79 | acyl-CoA biosynthetic process (GO:0071616) | 3.24778765 |
| 80 | thioester biosynthetic process (GO:0035384) | 3.24778765 |
| 81 | acylglycerol biosynthetic process (GO:0046463) | 3.24736290 |
| 82 | neutral lipid biosynthetic process (GO:0046460) | 3.24736290 |
| 83 | plasma lipoprotein particle remodeling (GO:0034369) | 3.23364200 |
| 84 | protein-lipid complex remodeling (GO:0034368) | 3.23364200 |
| 85 | macromolecular complex remodeling (GO:0034367) | 3.23364200 |
| 86 | homocysteine metabolic process (GO:0050667) | 3.22933643 |
| 87 | citrulline biosynthetic process (GO:0019240) | 3.22714859 |
| 88 | aromatic amino acid family catabolic process (GO:0009074) | 3.21235960 |
| 89 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.20124907 |
| 90 | cholesterol homeostasis (GO:0042632) | 3.18070993 |
| 91 | carnitine shuttle (GO:0006853) | 3.17723497 |
| 92 | lipoprotein transport (GO:0042953) | 3.17716155 |
| 93 | membrane lipid catabolic process (GO:0046466) | 3.16358690 |
| 94 | lipid storage (GO:0019915) | 3.16173390 |
| 95 | regulation of triglyceride metabolic process (GO:0090207) | 3.15056233 |
| 96 | negative regulation of fibrinolysis (GO:0051918) | 3.14851832 |
| 97 | sterol homeostasis (GO:0055092) | 3.14760916 |
| 98 | regulation of cholesterol homeostasis (GO:2000188) | 3.14178556 |
| 99 | flavonoid metabolic process (GO:0009812) | 3.10223436 |
| 100 | hormone catabolic process (GO:0042447) | 3.10167135 |
| 101 | drug transmembrane transport (GO:0006855) | 3.08028753 |
| 102 | tricarboxylic acid metabolic process (GO:0072350) | 3.07590649 |
| 103 | heme transport (GO:0015886) | 3.07091677 |
| 104 | bile acid biosynthetic process (GO:0006699) | 3.06667159 |
| 105 | alkaloid metabolic process (GO:0009820) | 3.06158946 |
| 106 | cysteine metabolic process (GO:0006534) | 3.05071874 |
| 107 | valine metabolic process (GO:0006573) | 3.04901606 |
| 108 | positive regulation of lipid storage (GO:0010884) | 3.04235844 |
| 109 | NADH metabolic process (GO:0006734) | 3.03419167 |
| 110 | urate metabolic process (GO:0046415) | 3.02413484 |
| 111 | apoptotic cell clearance (GO:0043277) | 3.02063903 |
| 112 | negative regulation of cholesterol transport (GO:0032375) | 3.02045584 |
| 113 | negative regulation of sterol transport (GO:0032372) | 3.02045584 |
| 114 | mitochondrial calcium ion transport (GO:0006851) | 3.00431783 |
| 115 | fatty acid beta-oxidation (GO:0006635) | 3.00068776 |
| 116 | acetyl-CoA metabolic process (GO:0006084) | 2.99611389 |
| 117 | lysine metabolic process (GO:0006553) | 2.99588234 |
| 118 | lysine catabolic process (GO:0006554) | 2.99588234 |
| 119 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.98851949 |
| 120 | kynurenine metabolic process (GO:0070189) | 2.94851119 |
| 121 | positive regulation of fatty acid oxidation (GO:0046321) | 2.94614044 |
| 122 | positive regulation of osteoblast proliferation (GO:0033690) | 2.94130684 |
| 123 | regulation of bile acid biosynthetic process (GO:0070857) | 2.93469680 |
| 124 | regulation of apoptotic cell clearance (GO:2000425) | 2.93373601 |
| 125 | drug catabolic process (GO:0042737) | 2.93178644 |
| 126 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.92775095 |
| 127 | ethanol oxidation (GO:0006069) | 2.91128613 |
| 128 | protein activation cascade (GO:0072376) | 2.90236239 |
| 129 | amino-acid betaine metabolic process (GO:0006577) | 2.89657714 |
| 130 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.89604843 |
| 131 | short-chain fatty acid metabolic process (GO:0046459) | 2.88814206 |
| 132 | regulation of guanylate cyclase activity (GO:0031282) | 2.88034353 |
| 133 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.87534596 |
| 134 | peptide catabolic process (GO:0043171) | 2.87381696 |
| 135 | phenylpropanoid metabolic process (GO:0009698) | 2.87125183 |
| 136 | tryptophan catabolic process (GO:0006569) | 2.86362011 |
| 137 | indole-containing compound catabolic process (GO:0042436) | 2.86362011 |
| 138 | indolalkylamine catabolic process (GO:0046218) | 2.86362011 |
| 139 | fatty acid oxidation (GO:0019395) | 2.86212266 |
| 140 | opsonization (GO:0008228) | 2.86082766 |
| 141 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.85882309 |
| 142 | plasma lipoprotein particle organization (GO:0071827) | 2.85002143 |
| 143 | sterol transport (GO:0015918) | 2.83476507 |
| 144 | cholesterol transport (GO:0030301) | 2.83476507 |
| 145 | regulation of fibrinolysis (GO:0051917) | 2.83178210 |
| 146 | bile acid metabolic process (GO:0008206) | 2.82978767 |
| 147 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.82931129 |
| 148 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.82931129 |
| 149 | fatty acid catabolic process (GO:0009062) | 2.81430757 |
| 150 | lipid oxidation (GO:0034440) | 2.81065860 |
| 151 | glyoxylate metabolic process (GO:0046487) | 2.80355504 |
| 152 | protein-lipid complex subunit organization (GO:0071825) | 2.80271325 |
| 153 | lipid homeostasis (GO:0055088) | 2.79728616 |
| 154 | complement activation (GO:0006956) | 2.78960196 |
| 155 | biotin metabolic process (GO:0006768) | 2.75755751 |
| 156 | tryptophan metabolic process (GO:0006568) | 2.74717497 |
| 157 | regulation of sterol transport (GO:0032371) | 2.74514091 |
| 158 | regulation of cholesterol transport (GO:0032374) | 2.74514091 |
| 159 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.73585234 |
| 160 | angiotensin maturation (GO:0002003) | 2.72398090 |
| 161 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.72058981 |
| 162 | xenobiotic catabolic process (GO:0042178) | 2.71968369 |
| 163 | bile acid and bile salt transport (GO:0015721) | 2.70614096 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.42649816 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.46433934 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.86774265 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.37923323 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.20236708 |
| 6 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.34339416 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.27338888 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.13235638 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.82023966 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.69553436 |
| 11 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.42671389 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.41622968 |
| 13 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.39092235 |
| 14 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.38543423 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.22714618 |
| 16 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.16589711 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.15019707 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.13161070 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.00712043 |
| 20 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.92259813 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 1.91297065 |
| 22 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.91178933 |
| 23 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.81103824 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.80749407 |
| 25 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.80213147 |
| 26 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.78685767 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.77303394 |
| 28 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.75448264 |
| 29 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.74112874 |
| 30 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.73910704 |
| 31 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.70263958 |
| 32 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.68324967 |
| 33 | RXR_22108803_ChIP-Seq_LS180_Human | 1.64995349 |
| 34 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.56210678 |
| 35 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.53761075 |
| 36 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.53743733 |
| 37 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.52362903 |
| 38 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.51983790 |
| 39 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.48753750 |
| 40 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.47330139 |
| 41 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.42036597 |
| 42 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.41680930 |
| 43 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.39269538 |
| 44 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.38215832 |
| 45 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.38165812 |
| 46 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.38042156 |
| 47 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.36915595 |
| 48 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.34112547 |
| 49 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.33385877 |
| 50 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.29349050 |
| 51 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.29036260 |
| 52 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.27107700 |
| 53 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.26428882 |
| 54 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.25760199 |
| 55 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.25600181 |
| 56 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.24801531 |
| 57 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.20876611 |
| 58 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.16682106 |
| 59 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.15295103 |
| 60 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13615527 |
| 61 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.11242241 |
| 62 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.08487322 |
| 63 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.07843566 |
| 64 | GATA2_19941826_ChIP-Seq_K562_Human | 1.06670399 |
| 65 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.03306770 |
| 66 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.03001482 |
| 67 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.01385695 |
| 68 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.00794198 |
| 69 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.00628225 |
| 70 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.99863204 |
| 71 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.99651805 |
| 72 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99167092 |
| 73 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.98689975 |
| 74 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.98486312 |
| 75 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.98111981 |
| 76 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.97841843 |
| 77 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.97841843 |
| 78 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97809463 |
| 79 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.96702723 |
| 80 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.96668228 |
| 81 | CBP_21632823_ChIP-Seq_H3396_Human | 0.96583677 |
| 82 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.96478623 |
| 83 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96278453 |
| 84 | CJUN_26792858_Chip-Seq_BT549_Human | 0.96217310 |
| 85 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.96034928 |
| 86 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.95257177 |
| 87 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.94994488 |
| 88 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.94672451 |
| 89 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.93811692 |
| 90 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.92857737 |
| 91 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91642567 |
| 92 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.90955023 |
| 93 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.90298237 |
| 94 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.90298237 |
| 95 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.89747767 |
| 96 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88879409 |
| 97 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.88574925 |
| 98 | SPI1_23127762_ChIP-Seq_K562_Human | 0.87853908 |
| 99 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.86718188 |
| 100 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.86681029 |
| 101 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.86331219 |
| 102 | NFYA_21822215_ChIP-Seq_K562_Human | 0.84350514 |
| 103 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.83835117 |
| 104 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.83299773 |
| 105 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.83194801 |
| 106 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.82951327 |
| 107 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82864690 |
| 108 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.82598471 |
| 109 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.81673777 |
| 110 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.81344632 |
| 111 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.81000303 |
| 112 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.80844277 |
| 113 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.80649128 |
| 114 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80545918 |
| 115 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.79948163 |
| 116 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.79057452 |
| 117 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.78818664 |
| 118 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.78750132 |
| 119 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.78750132 |
| 120 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78581871 |
| 121 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.77423239 |
| 122 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77390805 |
| 123 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.77379472 |
| 124 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.77197316 |
| 125 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77186308 |
| 126 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.77134756 |
| 127 | AR_20517297_ChIP-Seq_VCAP_Human | 0.77082946 |
| 128 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.76995170 |
| 129 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.76363488 |
| 130 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76183277 |
| 131 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.76001840 |
| 132 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.75981376 |
| 133 | ATF3_27146783_Chip-Seq_COLON_Human | 0.75393875 |
| 134 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.75276313 |
| 135 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.73669688 |
| 136 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.73663585 |
| 137 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.71902783 |
| 138 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.71560412 |
| 139 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.70959850 |
| 140 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.70916393 |
| 141 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.70609366 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.60753471 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.67166047 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 3.58740057 |
| 4 | MP0003718_maternal_effect | 3.43477192 |
| 5 | MP0005365_abnormal_bile_salt | 3.41013802 |
| 6 | MP0009840_abnormal_foam_cell | 3.19346541 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.13687718 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.00244723 |
| 9 | * MP0000627_abnormal_mammary_gland | 2.87445501 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.77025600 |
| 11 | MP0003705_abnormal_hypodermis_morpholog | 2.72380922 |
| 12 | MP0004147_increased_porphyrin_level | 2.58678261 |
| 13 | MP0003252_abnormal_bile_duct | 2.54191681 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.50684592 |
| 15 | MP0008438_abnormal_cutaneous_collagen | 2.32211250 |
| 16 | MP0005670_abnormal_white_adipose | 2.16154073 |
| 17 | MP0002254_reproductive_system_inflammat | 2.14608191 |
| 18 | MP0005083_abnormal_biliary_tract | 2.08507503 |
| 19 | MP0004043_abnormal_pH_regulation | 2.05831666 |
| 20 | MP0004130_abnormal_muscle_cell | 1.94994143 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 1.81421517 |
| 22 | MP0000609_abnormal_liver_physiology | 1.80710506 |
| 23 | MP0003300_gastrointestinal_ulcer | 1.80441411 |
| 24 | MP0005058_abnormal_lysosome_morphology | 1.76095499 |
| 25 | * MP0001881_abnormal_mammary_gland | 1.74449130 |
| 26 | MP0003724_increased_susceptibility_to | 1.71266949 |
| 27 | MP0003806_abnormal_nucleotide_metabolis | 1.68422804 |
| 28 | MP0003436_decreased_susceptibility_to | 1.67855441 |
| 29 | MP0004019_abnormal_vitamin_homeostasis | 1.65908114 |
| 30 | MP0005636_abnormal_mineral_homeostasis | 1.61530986 |
| 31 | MP0005332_abnormal_amino_acid | 1.58168557 |
| 32 | MP0005666_abnormal_adipose_tissue | 1.54952425 |
| 33 | MP0005275_abnormal_skin_tensile | 1.54146878 |
| 34 | MP0005395_other_phenotype | 1.47738907 |
| 35 | MP0003868_abnormal_feces_composition | 1.45987508 |
| 36 | MP0003303_peritoneal_inflammation | 1.44273950 |
| 37 | MP0010234_abnormal_vibrissa_follicle | 1.41707931 |
| 38 | MP0005319_abnormal_enzyme/_coenzyme | 1.41602142 |
| 39 | MP0002138_abnormal_hepatobiliary_system | 1.38065153 |
| 40 | MP0002876_abnormal_thyroid_physiology | 1.36727111 |
| 41 | MP0000678_abnormal_parathyroid_gland | 1.36233619 |
| 42 | MP0004185_abnormal_adipocyte_glucose | 1.34155325 |
| 43 | MP0003566_abnormal_cell_adhesion | 1.26372020 |
| 44 | MP0004947_skin_inflammation | 1.24088105 |
| 45 | MP0001958_emphysema | 1.23286385 |
| 46 | MP0000604_amyloidosis | 1.22779492 |
| 47 | MP0002098_abnormal_vibrissa_morphology | 1.20932721 |
| 48 | MP0002971_abnormal_brown_adipose | 1.20339734 |
| 49 | MP0001664_abnormal_digestion | 1.18948834 |
| 50 | MP0002419_abnormal_innate_immunity | 1.16892418 |
| 51 | MP0001533_abnormal_skeleton_physiology | 1.16434586 |
| 52 | MP0005167_abnormal_blood-brain_barrier | 1.15466143 |
| 53 | MP0009764_decreased_sensitivity_to | 1.15403610 |
| 54 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.14445623 |
| 55 | MP0009643_abnormal_urine_homeostasis | 1.12069211 |
| 56 | MP0009785_altered_susceptibility_to | 1.10698804 |
| 57 | MP0005023_abnormal_wound_healing | 1.09939157 |
| 58 | MP0010352_gastrointestinal_tract_polyps | 1.09883932 |
| 59 | MP0008469_abnormal_protein_level | 1.09789607 |
| 60 | MP0005464_abnormal_platelet_physiology | 1.09515580 |
| 61 | MP0003959_abnormal_lean_body | 1.09504198 |
| 62 | MP0004782_abnormal_surfactant_physiolog | 1.09450939 |
| 63 | MP0010368_abnormal_lymphatic_system | 1.09302874 |
| 64 | MP0001765_abnormal_ion_homeostasis | 1.08798761 |
| 65 | MP0002796_impaired_skin_barrier | 1.07448881 |
| 66 | MP0002060_abnormal_skin_morphology | 1.06187908 |
| 67 | MP0000343_altered_response_to | 1.05440399 |
| 68 | MP0001835_abnormal_antigen_presentation | 1.03002755 |
| 69 | MP0009763_increased_sensitivity_to | 1.02516127 |
| 70 | MP0005375_adipose_tissue_phenotype | 1.01887298 |
| 71 | MP0002837_dystrophic_cardiac_calcinosis | 1.00674269 |
| 72 | MP0005025_abnormal_response_to | 1.00358721 |
| 73 | MP0009115_abnormal_fat_cell | 0.98846184 |
| 74 | MP0000569_abnormal_digit_pigmentation | 0.98298648 |
| 75 | MP0005334_abnormal_fat_pad | 0.97991409 |
| 76 | MP0003075_altered_response_to | 0.96834073 |
| 77 | MP0002166_altered_tumor_susceptibility | 0.96699563 |
| 78 | MP0003690_abnormal_glial_cell | 0.95538019 |
| 79 | MP0009379_abnormal_foot_pigmentation | 0.93368991 |
| 80 | MP0003195_calcinosis | 0.92756813 |
| 81 | MP0003656_abnormal_erythrocyte_physiolo | 0.92363048 |
| 82 | MP0005645_abnormal_hypothalamus_physiol | 0.91815626 |
| 83 | MP0000598_abnormal_liver_morphology | 0.91540671 |
| 84 | MP0001764_abnormal_homeostasis | 0.91163678 |
| 85 | MP0009278_abnormal_bone_marrow | 0.90904640 |
| 86 | MP0000685_abnormal_immune_system | 0.87911587 |
| 87 | MP0003453_abnormal_keratinocyte_physiol | 0.87420249 |
| 88 | MP0000490_abnormal_crypts_of | 0.87335920 |
| 89 | MP0005410_abnormal_fertilization | 0.87123338 |
| 90 | MP0006082_CNS_inflammation | 0.85713810 |
| 91 | MP0003183_abnormal_peptide_metabolism | 0.84607122 |
| 92 | MP0005535_abnormal_body_temperature | 0.84471689 |
| 93 | MP0000249_abnormal_blood_vessel | 0.84229732 |
| 94 | MP0001845_abnormal_inflammatory_respons | 0.83117107 |
| 95 | MP0005387_immune_system_phenotype | 0.82626537 |
| 96 | MP0001790_abnormal_immune_system | 0.82626537 |
| 97 | MP0001873_stomach_inflammation | 0.81352444 |
| 98 | MP0003866_abnormal_defecation | 0.81155815 |
| 99 | MP0005164_abnormal_response_to | 0.79261659 |
| 100 | MP0005166_decreased_susceptibility_to | 0.79147322 |
| 101 | MP0005448_abnormal_energy_balance | 0.78367549 |
| 102 | MP0004858_abnormal_nervous_system | 0.78158792 |
| 103 | MP0010155_abnormal_intestine_physiology | 0.77787669 |
| 104 | MP0005409_darkened_coat_color | 0.76385683 |
| 105 | MP0008004_abnormal_stomach_pH | 0.76176162 |
| 106 | MP0002896_abnormal_bone_mineralization | 0.76108467 |
| 107 | MP0003448_altered_tumor_morphology | 0.75811146 |
| 108 | MP0001879_abnormal_lymphatic_vessel | 0.75537242 |
| 109 | MP0000538_abnormal_urinary_bladder | 0.74815735 |
| 110 | MP0003879_abnormal_hair_cell | 0.74257841 |
| 111 | MP0001849_ear_inflammation | 0.72938093 |
| 112 | MP0002136_abnormal_kidney_physiology | 0.70676155 |
| 113 | MP0001853_heart_inflammation | 0.70561748 |
| 114 | MP0003186_abnormal_redox_activity | 0.70327434 |
| 115 | MP0004264_abnormal_extraembryonic_tissu | 0.70140861 |
| 116 | MP0000477_abnormal_intestine_morphology | 0.70008015 |
| 117 | * MP0009642_abnormal_blood_homeostasis | 0.69377912 |
| 118 | MP0000377_abnormal_hair_follicle | 0.68801961 |
| 119 | MP0001216_abnormal_epidermal_layer | 0.68210015 |
| 120 | MP0004510_myositis | 0.67778416 |
| 121 | MP0010678_abnormal_skin_adnexa | 0.67742492 |
| 122 | MP0001501_abnormal_sleep_pattern | 0.67653431 |
| 123 | MP0002998_abnormal_bone_remodeling | 0.67557481 |
| 124 | MP0003172_abnormal_lysosome_physiology | 0.67504662 |
| 125 | MP0003828_pulmonary_edema | 0.66516285 |
| 126 | MP0001756_abnormal_urination | 0.65144723 |
| 127 | MP0002168_other_aberrant_phenotype | 0.64944957 |
| 128 | MP0003045_fibrosis | 0.64097874 |
| 129 | MP0003011_delayed_dark_adaptation | 0.63671142 |
| 130 | MP0002078_abnormal_glucose_homeostasis | 0.62419225 |
| 131 | MP0003279_aneurysm | 0.62218349 |
| 132 | MP0004272_abnormal_basement_membrane | 0.61439835 |
| 133 | MP0003638_abnormal_response/metabolism_ | 0.59980096 |
| 134 | MP0005501_abnormal_skin_physiology | 0.59286677 |
| 135 | MP0009765_abnormal_xenobiotic_induced | 0.59230706 |
| 136 | MP0003953_abnormal_hormone_level | 0.55753233 |
| 137 | MP0009697_abnormal_copulation | 0.54776464 |
| 138 | MP0002148_abnormal_hypersensitivity_rea | 0.53946257 |
| 139 | MP0001663_abnormal_digestive_system | 0.52594968 |
| 140 | MP0005451_abnormal_body_composition | 0.50780934 |
| 141 | MP0000230_abnormal_systemic_arterial | 0.47372586 |
| 142 | MP0000537_abnormal_urethra_morphology | 0.44860870 |
| 143 | MP0003329_amyloid_beta_deposits | 0.43671589 |
| 144 | * MP0003936_abnormal_reproductive_system | 0.43266432 |
| 145 | MP0005381_digestive/alimentary_phenotyp | 0.41786243 |
| 146 | MP0008260_abnormal_autophagy | 0.40314195 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperactive renin-angiotensin system (HP:0000841) | 5.31634871 |
| 2 | Decreased circulating renin level (HP:0003351) | 5.12944110 |
| 3 | Deep venous thrombosis (HP:0002625) | 4.82316140 |
| 4 | Complement deficiency (HP:0004431) | 4.80782364 |
| 5 | Xanthomatosis (HP:0000991) | 4.66546552 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 4.30639785 |
| 7 | Intrahepatic cholestasis (HP:0001406) | 3.98069357 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 3.94135206 |
| 9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.78653755 |
| 10 | Abnormality of complement system (HP:0005339) | 3.75805176 |
| 11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.70205993 |
| 12 | Epidermoid cyst (HP:0200040) | 3.55012016 |
| 13 | Hyperlipoproteinemia (HP:0010980) | 3.48908919 |
| 14 | Myocardial infarction (HP:0001658) | 3.45657415 |
| 15 | Hypolipoproteinemia (HP:0010981) | 3.44885692 |
| 16 | Hypercholesterolemia (HP:0003124) | 3.37137978 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.33604029 |
| 18 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.30232520 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 3.28832203 |
| 20 | Thin bony cortex (HP:0002753) | 3.25885009 |
| 21 | Gout (HP:0001997) | 3.25638910 |
| 22 | Alkalosis (HP:0001948) | 3.23622055 |
| 23 | Abnormality of the common coagulation pathway (HP:0010990) | 3.20717840 |
| 24 | Widely patent fontanelles and sutures (HP:0004492) | 3.19866274 |
| 25 | Abnormality of renin-angiotensin system (HP:0000847) | 3.19406244 |
| 26 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.18107331 |
| 27 | Prolonged partial thromboplastin time (HP:0003645) | 3.18041337 |
| 28 | Joint hemorrhage (HP:0005261) | 3.12661080 |
| 29 | Hyperglycinuria (HP:0003108) | 3.06570792 |
| 30 | Autoimmune thrombocytopenia (HP:0001973) | 3.05198218 |
| 31 | Right ventricular cardiomyopathy (HP:0011663) | 3.02833076 |
| 32 | Hydroxyprolinuria (HP:0003080) | 2.91707389 |
| 33 | Abnormality of proline metabolism (HP:0010907) | 2.91707389 |
| 34 | Hyperammonemia (HP:0001987) | 2.90119433 |
| 35 | Amyloidosis (HP:0011034) | 2.87810972 |
| 36 | Chronic diarrhea (HP:0002028) | 2.85870857 |
| 37 | Rickets (HP:0002748) | 2.83876173 |
| 38 | Glomerulonephritis (HP:0000099) | 2.80758613 |
| 39 | Hyperaldosteronism (HP:0000859) | 2.79689847 |
| 40 | Skin nodule (HP:0200036) | 2.78958849 |
| 41 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.76888243 |
| 42 | Abnormality of vitamin metabolism (HP:0100508) | 2.76469057 |
| 43 | Esophageal varix (HP:0002040) | 2.76027480 |
| 44 | Renal salt wasting (HP:0000127) | 2.74676576 |
| 45 | Fat malabsorption (HP:0002630) | 2.72505083 |
| 46 | Abnormality of the costochondral junction (HP:0000919) | 2.71253732 |
| 47 | Ketosis (HP:0001946) | 2.67984054 |
| 48 | Hypotension (HP:0002615) | 2.66205037 |
| 49 | Axonal loss (HP:0003447) | 2.65721911 |
| 50 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.60935436 |
| 51 | Eczematoid dermatitis (HP:0000976) | 2.58755782 |
| 52 | Hypophosphatemia (HP:0002148) | 2.58566937 |
| 53 | Abnormality of glycine metabolism (HP:0010895) | 2.58517972 |
| 54 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.58517972 |
| 55 | Steatorrhea (HP:0002570) | 2.57121895 |
| 56 | Hypoglycemic coma (HP:0001325) | 2.56183083 |
| 57 | Polycythemia (HP:0001901) | 2.53946981 |
| 58 | Increased purine levels (HP:0004368) | 2.52740326 |
| 59 | Hyperuricemia (HP:0002149) | 2.52740326 |
| 60 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.51747213 |
| 61 | Conjugated hyperbilirubinemia (HP:0002908) | 2.51720794 |
| 62 | Congenital sensorineural hearing impairment (HP:0008527) | 2.51124081 |
| 63 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.50616923 |
| 64 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.48926553 |
| 65 | Abnormality of vitamin B metabolism (HP:0004340) | 2.47685603 |
| 66 | Protuberant abdomen (HP:0001538) | 2.46490427 |
| 67 | Flat acetabular roof (HP:0003180) | 2.46178032 |
| 68 | Hyperkalemia (HP:0002153) | 2.45767098 |
| 69 | Symptomatic seizures (HP:0011145) | 2.44538830 |
| 70 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.43963297 |
| 71 | Glomerulosclerosis (HP:0000096) | 2.42539749 |
| 72 | Enlarged epiphyses (HP:0010580) | 2.42024041 |
| 73 | Abdominal distention (HP:0003270) | 2.39702353 |
| 74 | Abnormality of urine glucose concentration (HP:0011016) | 2.39421109 |
| 75 | Glycosuria (HP:0003076) | 2.39421109 |
| 76 | Metaphyseal irregularity (HP:0003025) | 2.36818014 |
| 77 | Hemorrhage of the eye (HP:0011885) | 2.36796167 |
| 78 | Abnormality of the intrinsic pathway (HP:0010989) | 2.35870063 |
| 79 | Abnormal tarsal ossification (HP:0008369) | 2.35663103 |
| 80 | Hypertriglyceridemia (HP:0002155) | 2.34231864 |
| 81 | Hematochezia (HP:0002573) | 2.32054625 |
| 82 | Abnormality of chloride homeostasis (HP:0011422) | 2.28907559 |
| 83 | Vacuolated lymphocytes (HP:0001922) | 2.27400852 |
| 84 | Increased mean platelet volume (HP:0011877) | 2.25335868 |
| 85 | Posterior subcapsular cataract (HP:0007787) | 2.23899959 |
| 86 | Gingival bleeding (HP:0000225) | 2.22498085 |
| 87 | Acanthocytosis (HP:0001927) | 2.22014589 |
| 88 | Elevated alkaline phosphatase (HP:0003155) | 2.21102343 |
| 89 | Peritonitis (HP:0002586) | 2.20992571 |
| 90 | Dehydration (HP:0001944) | 2.18509957 |
| 91 | * Abnormality of purine metabolism (HP:0004352) | 2.17592538 |
| 92 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.17256975 |
| 93 | Recurrent bacterial skin infections (HP:0005406) | 2.16183259 |
| 94 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.15879480 |
| 95 | Tubulointerstitial nephritis (HP:0001970) | 2.15855419 |
| 96 | Increased connective tissue (HP:0009025) | 2.15328248 |
| 97 | Ketoacidosis (HP:0001993) | 2.14909541 |
| 98 | Pigmentary retinal degeneration (HP:0001146) | 2.13383168 |
| 99 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.12784372 |
| 100 | Ileus (HP:0002595) | 2.11889423 |
| 101 | Spontaneous hematomas (HP:0007420) | 2.11092217 |
| 102 | * Nephritis (HP:0000123) | 2.10680802 |
| 103 | Hypokalemia (HP:0002900) | 2.09784204 |
| 104 | Abnormality of iron homeostasis (HP:0011031) | 2.09431275 |
| 105 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.09023025 |
| 106 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.08814591 |
| 107 | Abnormal platelet volume (HP:0011876) | 2.07887380 |
| 108 | Alopecia of scalp (HP:0002293) | 2.06354050 |
| 109 | Delayed epiphyseal ossification (HP:0002663) | 2.06289257 |
| 110 | Hypophosphatemic rickets (HP:0004912) | 2.06200355 |
| 111 | Proximal tubulopathy (HP:0000114) | 2.06088293 |
| 112 | Mitral stenosis (HP:0001718) | 2.04816452 |
| 113 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.04065481 |
| 114 | Osteolytic defects of the hand bones (HP:0009699) | 2.04065481 |
| 115 | Abnormal hair laboratory examination (HP:0003328) | 2.03628988 |
| 116 | Hyperglycinemia (HP:0002154) | 2.03488759 |
| 117 | Cerebral aneurysm (HP:0004944) | 2.03446620 |
| 118 | Pustule (HP:0200039) | 2.03048237 |
| 119 | * Nephrolithiasis (HP:0000787) | 2.03030709 |
| 120 | Generalized aminoaciduria (HP:0002909) | 2.02466825 |
| 121 | Vascular calcification (HP:0004934) | 2.02256834 |
| 122 | Cardiovascular calcification (HP:0011915) | 2.02235199 |
| 123 | Focal segmental glomerulosclerosis (HP:0000097) | 2.01946322 |
| 124 | Recurrent abscess formation (HP:0002722) | 2.00823418 |
| 125 | * Abnormality of nucleobase metabolism (HP:0010932) | 2.00015115 |
| 126 | Broad metatarsal (HP:0001783) | 1.97812330 |
| 127 | Irritability (HP:0000737) | 1.97687584 |
| 128 | Mucopolysacchariduria (HP:0008155) | 1.97583735 |
| 129 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.97583735 |
| 130 | Interstitial pulmonary disease (HP:0006530) | 1.97162239 |
| 131 | Gingivitis (HP:0000230) | 1.96358505 |
| 132 | Malnutrition (HP:0004395) | 1.95172880 |
| 133 | Thick nail (HP:0001805) | 1.93930157 |
| 134 | Villous atrophy (HP:0011473) | 1.93726747 |
| 135 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.93726747 |
| 136 | Asymmetric septal hypertrophy (HP:0001670) | 1.93103769 |
| 137 | Hyponatremia (HP:0002902) | 1.92745025 |
| 138 | Increased serum ferritin (HP:0003281) | 1.92601091 |
| 139 | Cerebral palsy (HP:0100021) | 1.91678750 |
| 140 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.90989646 |
| 141 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.90989646 |
| 142 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.90989646 |
| 143 | Loss of speech (HP:0002371) | 1.90594534 |
| 144 | Wide cranial sutures (HP:0010537) | 1.89681890 |
| 145 | Abnormality of macrophages (HP:0004311) | 1.89672993 |
| 146 | Periodontitis (HP:0000704) | 1.88692300 |
| 147 | Menorrhagia (HP:0000132) | 1.87915611 |
| 148 | Pancreatitis (HP:0001733) | 1.86614155 |
| 149 | Tetraparesis (HP:0002273) | 1.82466309 |
| 150 | Nausea (HP:0002018) | 1.80687518 |
| 151 | Dysostosis multiplex (HP:0000943) | 1.79964982 |
| 152 | Hepatocellular carcinoma (HP:0001402) | 1.79820515 |
| 153 | Abnormal cartilage morphology (HP:0002763) | 1.78216466 |
| 154 | Hyperbilirubinemia (HP:0002904) | 1.77247425 |
| 155 | Metabolic acidosis (HP:0001942) | 1.76434585 |
| 156 | Aortic aneurysm (HP:0004942) | 1.76195033 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.10786275 |
| 2 | ACVR1B | 3.60865058 |
| 3 | EPHA2 | 3.48305916 |
| 4 | TRIB3 | 3.29139239 |
| 5 | SIK1 | 3.24798190 |
| 6 | CAMK1D | 3.12541157 |
| 7 | RIPK1 | 2.69646435 |
| 8 | FGFR4 | 2.43644699 |
| 9 | MST1R | 2.37767186 |
| 10 | PKN2 | 2.36087742 |
| 11 | TYK2 | 2.26059257 |
| 12 | TTN | 2.24362595 |
| 13 | BCKDK | 2.23077705 |
| 14 | EPHB1 | 2.18827934 |
| 15 | CAMK1G | 2.18243152 |
| 16 | TGFBR2 | 2.10108848 |
| 17 | MAP2K6 | 2.05594131 |
| 18 | PTK6 | 2.04727346 |
| 19 | FRK | 2.01673650 |
| 20 | TAOK3 | 1.84432013 |
| 21 | STK39 | 1.78094931 |
| 22 | TBK1 | 1.75783691 |
| 23 | JAK1 | 1.70439783 |
| 24 | OXSR1 | 1.67472262 |
| 25 | MAP3K12 | 1.49939366 |
| 26 | MST4 | 1.44767282 |
| 27 | TIE1 | 1.40858595 |
| 28 | IRAK3 | 1.39653663 |
| 29 | MAP2K3 | 1.37200677 |
| 30 | MAP3K3 | 1.32702089 |
| 31 | CSK | 1.31242411 |
| 32 | KIT | 1.26666415 |
| 33 | IKBKE | 1.25769535 |
| 34 | LMTK2 | 1.25125800 |
| 35 | MAP3K14 | 1.24618781 |
| 36 | CSNK1A1 | 1.24471093 |
| 37 | NEK9 | 1.23401717 |
| 38 | FGFR3 | 1.22927990 |
| 39 | IRAK1 | 1.21425171 |
| 40 | PRKAA2 | 1.19970792 |
| 41 | JAK3 | 1.19681088 |
| 42 | LATS1 | 1.19584215 |
| 43 | EPHA3 | 1.18762573 |
| 44 | TESK1 | 1.18398025 |
| 45 | JAK2 | 1.08116902 |
| 46 | ZAP70 | 1.07091084 |
| 47 | BMPR2 | 1.01625852 |
| 48 | STK38L | 1.00709932 |
| 49 | MAP3K7 | 1.00534554 |
| 50 | NLK | 1.00041557 |
| 51 | ICK | 0.99592328 |
| 52 | PDGFRA | 0.99555167 |
| 53 | INSRR | 0.99300745 |
| 54 | PIK3CA | 0.97713622 |
| 55 | KDR | 0.97259107 |
| 56 | LRRK2 | 0.96512393 |
| 57 | MAP4K1 | 0.96077804 |
| 58 | GRK6 | 0.95254484 |
| 59 | STK24 | 0.94464114 |
| 60 | BMX | 0.92968078 |
| 61 | MET | 0.92528497 |
| 62 | BLK | 0.91718776 |
| 63 | STK10 | 0.91018745 |
| 64 | ARAF | 0.88580920 |
| 65 | DAPK2 | 0.87209413 |
| 66 | PTK2 | 0.87042742 |
| 67 | TRPM7 | 0.86579086 |
| 68 | MAPK11 | 0.85613050 |
| 69 | MAP3K9 | 0.83594485 |
| 70 | PDGFRB | 0.83373276 |
| 71 | MAP3K10 | 0.83227775 |
| 72 | CDK6 | 0.78361170 |
| 73 | GRK7 | 0.76309342 |
| 74 | MYLK | 0.74444213 |
| 75 | GRK1 | 0.73056567 |
| 76 | PRKG2 | 0.72669002 |
| 77 | PINK1 | 0.72545497 |
| 78 | FER | 0.71736838 |
| 79 | TESK2 | 0.70330255 |
| 80 | FLT3 | 0.69526915 |
| 81 | EPHB2 | 0.69266228 |
| 82 | CAMK2D | 0.68261804 |
| 83 | IRAK4 | 0.67942396 |
| 84 | PRKACG | 0.67877271 |
| 85 | PDPK1 | 0.66390493 |
| 86 | CSF1R | 0.66367858 |
| 87 | STK38 | 0.64290681 |
| 88 | ERBB3 | 0.63201391 |
| 89 | NEK6 | 0.62565276 |
| 90 | MAP3K13 | 0.62232945 |
| 91 | HCK | 0.62064724 |
| 92 | FGFR2 | 0.62061797 |
| 93 | PDK4 | 0.61854375 |
| 94 | PDK3 | 0.61854375 |
| 95 | CASK | 0.59104681 |
| 96 | ERBB4 | 0.58881210 |
| 97 | DDR2 | 0.57513176 |
| 98 | BCR | 0.57007242 |
| 99 | GSK3A | 0.56637090 |
| 100 | PIK3CG | 0.55922886 |
| 101 | PDK2 | 0.54317773 |
| 102 | RET | 0.54013098 |
| 103 | STK3 | 0.53949303 |
| 104 | PRKCD | 0.53751840 |
| 105 | MAP3K2 | 0.53390673 |
| 106 | ITK | 0.52962815 |
| 107 | IKBKB | 0.52316628 |
| 108 | MAPK12 | 0.51713417 |
| 109 | SGK3 | 0.51547799 |
| 110 | CHUK | 0.51281319 |
| 111 | EGFR | 0.48913327 |
| 112 | MAPKAPK3 | 0.48712625 |
| 113 | CAMK2G | 0.48535683 |
| 114 | IGF1R | 0.48052013 |
| 115 | FGR | 0.47845297 |
| 116 | PRKD1 | 0.47331593 |
| 117 | MAP2K2 | 0.47234008 |
| 118 | PRKCZ | 0.46673229 |
| 119 | PRKAA1 | 0.46197630 |
| 120 | PRKCE | 0.45417168 |
| 121 | RIPK4 | 0.45380094 |
| 122 | EIF2AK3 | 0.44372745 |
| 123 | PAK4 | 0.44231235 |
| 124 | ABL2 | 0.43904699 |
| 125 | MTOR | 0.43782054 |
| 126 | SRC | 0.43655492 |
| 127 | PRKCA | 0.43262645 |
| 128 | ERBB2 | 0.42328026 |
| 129 | PDK1 | 0.40564482 |
| 130 | CAMK2B | 0.40323233 |
| 131 | MATK | 0.40239058 |
| 132 | MAP3K11 | 0.39301327 |
| 133 | MUSK | 0.39157661 |
| 134 | PRKCH | 0.38907412 |
| 135 | MAP3K1 | 0.38658851 |
| 136 | EEF2K | 0.38292580 |
| 137 | MOS | 0.38233638 |
| 138 | NME2 | 0.37669117 |
| 139 | BTK | 0.37445824 |
| 140 | ABL1 | 0.37370292 |
| 141 | TAOK1 | 0.36893077 |
| 142 | KSR2 | 0.32042149 |
| 143 | YES1 | 0.29481050 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.96998831 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.72160486 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.70722712 |
| 4 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.59273170 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.57382719 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.53126181 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48362279 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.43339495 |
| 9 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.31543037 |
| 10 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.27063258 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.19033577 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.08150124 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.04775178 |
| 14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.03044846 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.96574466 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.90045324 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.84250266 |
| 18 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.78415237 |
| 19 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.77509280 |
| 20 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.76671344 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.71446311 |
| 22 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.70339880 |
| 23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.61649771 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.59368910 |
| 25 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.56576304 |
| 26 | * Peroxisome_Homo sapiens_hsa04146 | 1.49438192 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.46815066 |
| 28 | Bile secretion_Homo sapiens_hsa04976 | 1.43809348 |
| 29 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.42408003 |
| 30 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.40025653 |
| 31 | Galactose metabolism_Homo sapiens_hsa00052 | 1.39661888 |
| 32 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.38808091 |
| 33 | ABC transporters_Homo sapiens_hsa02010 | 1.38583510 |
| 34 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.30525128 |
| 35 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.27951235 |
| 36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.21212559 |
| 37 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.20472328 |
| 38 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.18194878 |
| 39 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.18009599 |
| 40 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.17243470 |
| 41 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.14707331 |
| 42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.14143812 |
| 43 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.09145450 |
| 44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.07406479 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 1.06821935 |
| 46 | * Caffeine metabolism_Homo sapiens_hsa00232 | 1.02079825 |
| 47 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.01614278 |
| 48 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.96754877 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.94591303 |
| 50 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.94272979 |
| 51 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.92720700 |
| 52 | Insulin resistance_Homo sapiens_hsa04931 | 0.90873614 |
| 53 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.89674324 |
| 54 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.89170274 |
| 55 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.88368401 |
| 56 | Lysine degradation_Homo sapiens_hsa00310 | 0.88234843 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86559464 |
| 58 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.86363127 |
| 59 | * Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.79991570 |
| 60 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.78803386 |
| 61 | Mineral absorption_Homo sapiens_hsa04978 | 0.76706571 |
| 62 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.75760254 |
| 63 | Pertussis_Homo sapiens_hsa05133 | 0.74855372 |
| 64 | Leishmaniasis_Homo sapiens_hsa05140 | 0.71665985 |
| 65 | Lysosome_Homo sapiens_hsa04142 | 0.68645658 |
| 66 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.67849016 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64606924 |
| 68 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.64324780 |
| 69 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.64273159 |
| 70 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.63498017 |
| 71 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63253783 |
| 72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62884821 |
| 73 | Malaria_Homo sapiens_hsa05144 | 0.61096340 |
| 74 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.58603652 |
| 75 | Amoebiasis_Homo sapiens_hsa05146 | 0.57402313 |
| 76 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.57151983 |
| 77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.56711192 |
| 78 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.55427703 |
| 79 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.55308052 |
| 80 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.54973676 |
| 81 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50001617 |
| 82 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.49988623 |
| 83 | Asthma_Homo sapiens_hsa05310 | 0.49554898 |
| 84 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.49543023 |
| 85 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.49249313 |
| 86 | Sulfur relay system_Homo sapiens_hsa04122 | 0.49064678 |
| 87 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48899560 |
| 88 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.47920208 |
| 89 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.46379510 |
| 90 | Other glycan degradation_Homo sapiens_hsa00511 | 0.44965044 |
| 91 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.43700730 |
| 92 | Hepatitis C_Homo sapiens_hsa05160 | 0.43594613 |
| 93 | Tuberculosis_Homo sapiens_hsa05152 | 0.41148830 |
| 94 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.40240139 |
| 95 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.36681481 |
| 96 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.35822616 |
| 97 | Legionellosis_Homo sapiens_hsa05134 | 0.33920657 |
| 98 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.32935863 |
| 99 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.32468935 |
| 100 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.32296616 |
| 101 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.31686944 |
| 102 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.29511661 |
| 103 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.27992818 |
| 104 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.27294847 |
| 105 | Influenza A_Homo sapiens_hsa05164 | 0.26859447 |
| 106 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26668122 |
| 107 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.25576530 |
| 108 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.25444679 |
| 109 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.25009102 |
| 110 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.24875374 |
| 111 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.24482261 |
| 112 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.24113494 |
| 113 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.23853198 |
| 114 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.23835328 |
| 115 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.23796960 |
| 116 | Allograft rejection_Homo sapiens_hsa05330 | 0.23128981 |
| 117 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.21912448 |
| 118 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.19183443 |
| 119 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.18156627 |
| 120 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.09569611 |
| 121 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.08359674 |
| 122 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.07512514 |
| 123 | Salivary secretion_Homo sapiens_hsa04970 | 0.04879806 |

